University of Arkansas Customized Coding Seminar (2018)

January 12, 2018

Practice Gap: New CPT and ICD-10-CM codes have been introduced and physicians and the staff of urology practices do not have the knowledge to accurately apply correct codes for diseases, signs and symptoms, and external causes of injury or disease.

Educational Need: Physicians and staff in urology practices need training to understand and apply the new CPT and ICD-10-CM codes to ensure procedures are properly coded for accurate billing.

Target Audience

  • Urologists
  • Practice Managers
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Medical Technicians

    Learning Objectives

    After completing this activity, particpants will be able to:

    1. List the changes to the Medicare Program for 2018
    2. Code complex urological issues and multiple procedures
    3. Determine coding for the appropriate level of evaluation and management services
    4. Describe coding information to use in the everyday practice
    5. Describe the relationship between encounter documentation and code selection
    Course summary
    Available credit: 
    • 6.25 AMA PRA Category 1 Credit™
    • 6.25 Non-Physician Participation
    Course opens: 
    01/12/2018
    Course expires: 
    01/12/2021
    Event starts: 
    01/12/2018 - 12:00am
    Event ends: 
    01/12/2018 - 11:59pm
    Rating: 
    0

    8:00 - 8:30am: Welcome, Introductions, Objectives

    8:30 - 9:00am: Review 2018 CPT Coding Changes Affecting Urologists

    9:00 -10:15am: Review of Modifiers for E&M and Urology Procedures

    10:15 -10:30am: Break

    10:30- 11:30am: Urology Services Commonly Miscoded

    11:30 – 12:30: RVU changes for 2018

    12:00 -12:30pm: Lunch

    12:30 - 1:00pm: Review of Procedural Coding

    1:00 - 2:30pm: E&M Guidelines and Medical Necessity

    2:00 – 3:00pm: Open discussion of problems and Q&A

    Little Rock, AR
    United States

    Faculty Disclosures: 
    Enda Maldonado; AUA Coding Educator: Nothing to Disclose

    Planner Disclosures: 
    Joel Dunay; Senior Manager, AUA Practice Management Department: Nothing to Disclose
    Victor Nitti, MD; Chair, AUA Office of Education: Serenity Pharmaceticals, Investtment Interest
    Brant Inman, MD: Chair, AUA Content Review Work Group: Combat Medical, Consultant/Advisor; BioCancell, Consultant/Advisor; Nucleix, Scientific Study/Trial; Urogen, Scientific Study/Trial

    Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation: The American Urological Association designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

    Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

    Available Credit

    • 6.25 AMA PRA Category 1 Credit™
    • 6.25 Non-Physician Participation

    Accreditation Period

    Course opens: 
    01/12/2018
    Course expires: 
    01/12/2021
    Please login or register to take this course.